MINI FUTURE SHORT - DIASORIN Stock

DE000PN4VNQ2

Delayed Deutsche Boerse AG 07:21:09 2024-07-03 EDT
3.97 ^EUR	-5.48%

Current month	-8.10%
1 month	+6.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

Milan stock market up sharply after Powell, Mps and Bper run, Leonardo good	07:42am	RE
Funds move on DiaSorin, Iveco and STM.	06-26	AN
Funds move on Mib, Mid and Small.	06-21	AN
Funds raise short on De Nora and Ariston.	06-18	AN

More news

Quotes 5-day view

Date	Price	Change
24-07-03	3.97	-5.48%
24-07-02	4.2	-7.08%
24-07-01	4.52	-1.09%
24-06-28	4.57	+1.33%
24-06-27	4.51	-0.66%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 07:21 am

More quotes

Static data

Product type	Knock-Out mit Stop Loss
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
WKN	PN4VNQ
ISIN	DE000PN4VNQ2
Date issued	2023-06-16
Strike	138.5 €
Maturity	Unlimited
Parity	10 : 1
Emission price	4.19 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	5.87 €
Lowest since issue	3.64 €
Spread	0.01 €
Spread %	0.25%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

96.48 EUR

Average target price

101.7 EUR

Spread / Average Target

+5.37%

Consensus